Drugmakers that refuse to negotiate could face steep penalties. Companies that raise prices beyond inflation would have to pay rebates to Medicare.
Trump promised to release a new health care plan, but those close to the White House told the Washington Post that no such plan is going to materialize.
We’re in a phase of a familiar cycle.
Trump wants to supersize a program that spent almost a quarter of its funds on overhead.